The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Alpine Immune Sciences | Common Stock | 02083G100 | 17,272 | 2,029,580 | SH | SOLE | 2,029,580 | 0 | 0 | ||
Arcutis Biothereapeutics | Common Stock | 03969K108 | 13,294 | 623,836 | SH | SOLE | 623,836 | 0 | 0 | ||
Cincor Pharma | Common Stock | 17240Y109 | 18,203 | 966,176 | SH | SOLE | 966,176 | 0 | 0 | ||
ESSA Pharma | Common Stock | 29668H708 | 1,034 | 328,196 | SH | SOLE | 328,196 | 0 | 0 | ||
Gossamer Bio | Common Stock | 38341P102 | 12,555 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
Ikena Oncology | Common Stock | 45175G108 | 9,964 | 2,249,123 | SH | SOLE | 2,249,123 | 0 | 0 | ||
Imago Biosciences | Common Stock | 45250K107 | 40,421 | 3,018,737 | SH | SOLE | 3,018,737 | 0 | 0 | ||
Immunic Inc | Common Stock | 4525EP101 | 6,205 | 1,788,160 | SH | SOLE | 1,788,160 | 0 | 0 | ||
Immunocore Holdings | ADS | 45258D105 | 1,923 | 51,535 | SH | SOLE | 51,535 | 0 | 0 | ||
Jounce Therapeutics | Common Stock | 481116101 | 835 | 275,513 | SH | SOLE | 275,513 | 0 | 0 | ||
Kronos Bio | Common Stock | 50107A104 | 13,899 | 3,818,283 | SH | SOLE | 3,818,283 | 0 | 0 | ||
Morphic Holding | Common Stock | 61775R105 | 21,934 | 1,010,769 | SH | SOLE | 1,010,769 | 0 | 0 | ||
Nuvation Bio | Common Stock Class A | 67080N101 | 49,401 | 15,247,340 | SH | SOLE | 15,247,340 | 0 | 0 | ||
Omega Alpha SPAC | Common Stock Class A | G6749V107 | 4,935 | 501,000 | SH | SOLE | 501,000 | 0 | 0 | ||
Paratek Pharmaceuticals | Common Stock | 699374302 | 3,804 | 1,971,241 | SH | SOLE | 1,971,241 | 0 | 0 | ||
Replimune Group | Common Stock | 76029N106 | 81,691 | 4,673,380 | SH | SOLE | 4,673,380 | 0 | 0 | ||
Sana Biotechnology, Inc. | Common Stock | 799566104 | 5,425 | 843,750 | SH | SOLE | 843,750 | 0 | 0 | ||
Senti Biosciences, Inc. | Common Stock | 81726A100 | 386 | 195,792 | SH | SOLE | 195,792 | 0 | 0 | ||
Spruce Biosciences | Common Stock | 85209E109 | 3,760 | 2,161,022 | SH | SOLE | 2,161,022 | 0 | 0 | ||
Syros Pharmaceuticals | Common Stock | 87184Q107 | 2,419 | 2,512,705 | SH | SOLE | 2,512,705 | 0 | 0 | ||
Theseus Pharmaceuticals | Common Stock | 88369M101 | 3,934 | 711,479 | SH | SOLE | 711,479 | 0 | 0 |